North American Science Associates, Inc. Logo
2016-02-04 17:10
NAMSA Announces Divestiture of its Sterility Assurance Products Division
  • Crosstex to acquire NAMSA’s Products Division to grow global sales of Sterilization Products in the industrial market
NORTHWOOD, OHIO--(Business Wire/Korea Newswire) February 4, 2016 -- North American Science Associates, Inc. (NAMSA), the world’s leading medical research organization (MRO®) today announced a definitive agreement to divest its Sterility Assurance Products Division of biological and chemical indicators. Crosstex International, Inc. (Crosstex), dedicated to delivering innovative infection prevention products for patients, caregivers, and other healthcare providers, will acquire the assets of NAMSA’s Products business to further expand their offerings in the industrial market. The divestiture is consistent with NAMSA’s strategy to focus the organization on preclinical and clinical services that support the MRO® Approach, which offers a combination of regulatory and quality consulting, laboratory testing and clinical research to reduce time to market for its clients.

As part of Crosstex, the industrial sterilization monitoring portfolio will be well positioned to continue to grow its global leadership position. This transaction will complement the biological monitoring portfolio of Crosstex, which is currently focused in the dental and medical markets. Crosstex will provide industrial clients sterilization monitoring products with the same level of service and support that they receive from NAMSA today with an expanded product offering.

After the transaction closes, NAMSA will continue to manufacture sterilization monitoring products (for Crosstex) through the middle of 2016 depending on the product configuration, at which time Crosstex will integrate manufacturing into its global supply chain.

Subject to customary closing conditions, NAMSA (and Crosstex) expect the transaction to close in the first quarter of 2016.

About NAMSA

NAMSA (www.namsa.com) is the global medical research organization, providing comprehensive services to advise clients and evaluate the safety and efficacy of medical devices, IVDs and combination products. For nearly 50 years, NAMSA clients have utilized its consulting, testing and clinical services to bring safe and effective products to market.

About Crosstex

A Cantel Medical Corp. (NYSE:CMN); Crosstex (www.crosstex.com) manufactures a wide array of unique and innovative infection prevention and control products for the global healthcare industry. Founded in 1953 and headquartered in Hauppauge, New York, Crosstex is a recognized leader for its portfolio of biological and chemical indicators, sterility assurance packaging and personal protection equipment (PPE). With the acquisition of SPSmedical in 2012 Crosstex further broadened and strengthened its position in the acute-care and alternate-care markets. Sold in more than 100 countries, the range of products distributed to medical, dental and veterinary practices and facilities include our award winning (5 consecutive years) Secure Fit technology face masks, DentaPure waterline treatment cartridges, Sure-Check sterilization pouches with internal/external multi-parameter indicators, Tyvek pouches with 510K approval, Steam Plus Type 5 chemical integrators, ConFirm and Passport Plus in-office and mail-in biological indicators, Rapicide OPA/28 high level disinfectant, intermediate level surface disinfectant spray and wipes, hand sanitizers, enzymatic detergent/cleaner, gloves and a full array of single-use disposables.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160203005204/en/
  • Media Contact
  • NAMSA
    Jane Kervin
    Corporate Vice President Mergers & Acquisitions
    866-666-9455
    jkervin@namsa.com
    www.namsa.com

    Crosstex
    Andrew Whitehead
    Sr. VP Marketing and Business Development
    andyw@crosstex.com
    www.crosstex.com
North American Science Associates, Inc. 전체 보도자료 보기
이 뉴스는 기업·기관이 발표한 보도자료 전문입니다. 언론 매체와 블로그는 보도를 목적으로 이 보도자료를 사용할 수 있습니다. 보도자료 등록 안내
Media Contact

NAMSA
Jane Kervin
Corporate Vice President Mergers & Acquisitions
866-666-9455
jkervin@namsa.com
www.namsa.com

Crosstex
Andrew Whitehead
Sr. VP Marketing and Business Development
andyw@crosstex.com
www.crosstex.com

이 보도자료 관련 분야

건강  의료기기  인수/합병  해외

관심 분야 보도자료 구독 방법

가입하면 관심 분야 보도자료를 마이 뉴스와 이메일로 볼 수 있습니다. 스마트폰과 RSS로도 가능합니다.

보도자료 배포 서비스 안내

뉴스와이어는 4천여개 언론매체에서 일하는 1만7천여명의 기자에 보도자료를 배포해 언론이 보도할 수 있게 합니다.

해외 보도자료 배포 안내
비즈니스와이어와 제휴해 해외 언론에 보도자료를 배포합니다.